ReviewThe FEBS journal2026

Understanding and addressing resistance to IMiDs immunomodulatory compounds in multiple myeloma.

Maria-Cynthia Fuentes-Lacouture et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.